The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 10,601–10,700 of 31,469
The Protective Effect of Theaflavins on the Kidney of Mice with Type II Diabetes Mellitus
Wang, J., Jiang, J., Zhao, C., et al. (2022) · Nutrients · doi:10.3390/nu15010201 · Cited by 33
Cossins, B. C., van den Munckhof, I., Rutten, J. H. W., van der Graaf, M., Stienstra, R., Joosten, L. A. B., Netea, M. G., Li, Y., & Riksen, N. P. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad193 · Cited by 35
Brzozowska, M. M., Isaacs, M., Bliuc, D., Baldock, P. A. J., Eisman, J. A., White, C., & Greenfield, J. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-33317-6 · Cited by 38
Seah, J. Y. H., Sim, X., Khoo, C. M., Tai, E. S., & van Dam, R. M. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003385 · Cited by 35
Aquilani, R., Ramusino, M. C., Maestri, R., Iadarola, P., Boselli, M., Perini, G., Boschi, F., Dossena, M., Bellini, A., Buonocore, D., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1237469 · Cited by 34
Lauw, S., Kei, N., Chan, P. L., Yau, T. K., Lee, K., Szeto, C. Y. Y., Lin, J. S.-C., Wong, S. H., Cheung, P. C. K., & Kwan, H. S. (2023) · Nutrients · doi:10.3390/nu15194248 · Cited by 39
Bazyar, H., Javid, A. Z., Masoudi, M. R., Haidari, F., Heidari, Z., Hajializadeh, S., Aghamohammadi, V., & Vajdi, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-59659-3 · Cited by 33
Rinaldi, R., Nucci, S. D., Donghia, R., Donvito, R., Cerabino, N., Chito, M. D., Penza, A., Mongelli, F. P., Shahini, E., Zappimbulso, M., et al. (2024) · Nutrients · doi:10.3390/nu16101408 · Cited by 35
Mei, Y., Li, Y., Zhang, B., et al. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00945-z · Cited by 33
Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes
Ji, L., Ma, J., Ma, Y., Cheng, Z., Gan, S., Yuan, G., Liu, D., Li, S., Liu, Y., Xue, X., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.62185 · Cited by 40
Die zwei deutschen Geburtskohorten GINIplus und LISAplus
Heinrich, J., Brüske, I., Schnappinger, M., Standl, M., Flexeder, C., Thiering, E., Tischer, C., Tiesler, C. M. T., Kohlböck, G., Wenig, C. M., et al. (2012) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-012-1485-4 · Cited by 33
Park, J., Cho, B., Kwon, H., Prilutsky, D., Yun, J. M., Choi, H.-C., Hwang, K., Lee, I., Kim, J., & Kong, S. W. (2015) · Liver International · doi:10.1111/liv.12909 · Cited by 35
Bhatt, S. P., Misra, A., Sharma, M., Guleria, R., Pandey, R. M., Luthra, K., & Vikram, N. K. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0303 · Cited by 33
de Luis, D. A., Aller, R., Izaola, O., Primo, D., Urdiales, S., & Romero, E. (2015) · Lifestyle Genomics · doi:10.1159/000441142 · Cited by 33
Rosini, N., Moura, S. A. Z. O., Rosini, R. D., et al. (2015) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20150040 · Cited by 33
Şengül, E., Duygulu, G., Dindar, S., & Bunul, F. (2013) · Renal Failure · doi:10.3109/0886022x.2013.817256 · Cited by 33
Woo, Y. C., Tso, A. W. K., Xu, A., Law, L. S., Fong, C. H.-Y., Lam, T.-H., Lo, S., Wat, N. M. S., Cheung, B. M. Y., & Lam, K. S. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036868 · Cited by 33
Guimarães, M. M., Carvalho, A. C. M. S., & Silva, M. S. (2013) · Journal of the American College of Nutrition · doi:10.1080/07315724.2013.816598 · Cited by 33
Ward-Caviness, C. K., Kraus, W. E., Blach, C., Haynes, C. S., Dowdy, E., Miranda, M. L., Devlin, R. B., Díaz-Sánchez, D., Cascio, W. E., Mukerjee, S., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1306980 · Cited by 33
Calarge, C. A., Nicol, G. E., Schlechte, J., & Burns, T. L. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0126 · Cited by 33
Bayham, B. E., Greenway, F. L., Johnson, W. D., & Dhurandhar, N. V. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.02.002 · Cited by 33
Moderate dietary weight loss reduces myocardial steatosis in obese and overweight women
Utz, W., Engeli, S., Haufe, S., Kast, P., Böhnke, J., Haas, V. K., Hermsdorf, M., Wiesner, S., Pofahl, M., Traber, J., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.104 · Cited by 33
Bayram, F., Koçer, D., Özsan, M., & Muhtaroğlu, S. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.569607 · Cited by 34
Relation with HOMA-IR and thyroid hormones in obese Turkish women with metabolic syndrome
Topsakal, Ş., Yerli̇kaya, E., Akın, F., et al. (2012) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03325329 · Cited by 33
Olson, K. J., Hendricks, B. L., & Murdock, D. K. (2012) · Cholesterol · doi:10.1155/2012/794252 · Cited by 33
Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients
Guzmán, M. G., García–Álvarez, M., Berenguer, J., Jiménez‐Sousa, M. Á., Cosín, J., Tenor, D. P., Carrero, A., Aldámiz‐Echevarría, T., Álvarez, E., López, J. C., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.10.011 · Cited by 33
Mager, D. R., Mazurak, V. C., Rodriguez‐Dimitrescu, C., Vine, D. F., Jetha, M. M., Ball, G. D. C., & Yap, J. Y. K. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112467820 · Cited by 34
Siddiqui, M. S., Cheang, K. L., Luketic, V. A., Boyett, S. L., Idowu, M. O., Patidar, K. R., Puri, P., Matherly, S. C., Stravitz, R. T., Sterling, R. K., et al. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3627-7 · Cited by 33
Short-term outcomes of community-based adolescent weight management: The Loozit® Study
Shrewsbury, V. A., Nguyen, B., O’Connor, J., Steinbeck, K. S., Lee, A., Hill, A. J., Shah, S., Kohn, M. R., Torvaldsen, S., & Baur, L. A. (2011) · BMC Pediatrics · doi:10.1186/1471-2431-11-13 · Cited by 33
Negi, A., Ramarao, P., & Kumar, R. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557511313050004 · Cited by 33
Cankaya, S., Demir, B., Aksakal, S. E., Dilbaz, B., Demirtas, C., & Göktolga, Ü. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.05.032 · Cited by 33
A Comparative Study of Gastric Banding and Sleeve Gastrectomy in an Obese Diabetic Rat Model
Masuda, T., Ohta, M., Hirashita, T., Kawano, Y., Eguchi, H., 矢田, 一., Iwashita, Y., & Kitano, S. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0512-0 · Cited by 33
Yarborough, B. J. H., Leo, M. C., Stumbo, S. P., Perrin, N., & Green, C. A. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-238 · Cited by 35
The role of adiponectin multimers in anorexia nervosa
Amitani, H., Asakawa, A., Ogiso, K., Nakahara, T., Ushikai, M., Haruta, I., Koyama, K.-I., Amitani, M. S., Cheng, K., & Inui, A. (2012) · Nutrition · doi:10.1016/j.nut.2012.07.011 · Cited by 36
Yun, J. E., Won, S., Sung, J., & Jee, S. H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0125 · Cited by 33
Awad, S., & Lobo, D. N. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834f0078 · Cited by 34
Obese Reproductive‐Age Women Exhibit a Proatherogenic Inflammatory Response During Hyperglycemia
González, F., Rote, N. S., Minium, J., O’Leary, V. B., & Kirwan, J. P. (2007) · Obesity · doi:10.1038/oby.2007.289 · Cited by 33
Sex Hormones, Insulin Resistance, and Diabetes Mellitus Among Men With or at Risk for HIV Infection
Monroe, A. K., Dobs, A. S., Xu, X., Palella, F. J., Kingsley, L., Witt, M. D., & Brown, T. T. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182278c09 · Cited by 34
Tentolouris, N., Αλεξιάδου, Κ., Kokkinos, A. D., Koukou, E., Perrea, D. N., Kyriaki, D., & Katsilambros, N. L. (2010) · Nutrition · doi:10.1016/j.nut.2010.02.007 · Cited by 33
Koulouridis, E., Georgalidis, K., Kostimpa, I., Koulouridis, I., Krokida, A., & Houliara, D. (2009) · Pediatric Nephrology · doi:10.1007/s00467-009-1364-x · Cited by 33
Derosa, G., Bonaventura, A., Bianchi, L., Romano, D., Fogari, E., D’Angelo, A., & Maffioli, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.008 · Cited by 33
Adipocytokines and Insulin Resistance across Various Degrees of Glucose Tolerance in Pregnancy
Skvarča, A., Tomažič, M., Krhin, B., Blagus, R., & Janež, A. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000220 · Cited by 34
Masternak, M. M., Panici, J. A., Wang, F., Wang, Z., & Spong, A. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp172 · Cited by 34
Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway
Tan, B. K., Chen, J., Adya, R., Ramanjaneya, M., Patel, V. C., & Randeva, H. S. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0277 · Cited by 33
Wang, X., Hsu, F.-C., Isom, S. P., Walkup, M. P., Kritchevsky, S. B., Goodpaster, B. H., Church, T., Pahor, M., Stafford, R. S., & Nicklas, B. J. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr187 · Cited by 35
Berry, D. C., Neal, M., Hall, E., Schwartz, T. A., Verbiest, S., Bonuck, K. A., Goodnight, W., Brody, S. C., Dorman, K. F., Menard, M. K., et al. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-184 · Cited by 35
Petta, S., Rosso, C., Leung, R. C., et al. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.022 · Cited by 33
Comparison of diagnostic criteria of the metabolic syndrome in 3 ethnic groups of Canada
Château‐Degat, M., Dewailly, É., Poirier, P., Gingras, S., & Egeland, G. M. (2008) · Metabolism · doi:10.1016/j.metabol.2008.06.006 · Cited by 33
de Moura, R. S., da Costa, G. F., Moreira, A. S. B., et al. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01395.x · Cited by 33
Bonfigli, A. R., Sirolla, C., Testa, R., Cucchi, M., Spazzafumo, L., Salvioli, S., Ceriello, A., Olivieri, F., Festa, R., Procopio, A. D., et al. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0450-x · Cited by 34
Chester, R. C., Sander, G. E., Fernandez, C., et al. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.05.007 · Cited by 33
Shabana, N. A., & Hasnain, S. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.001 · Cited by 33
Plasma fetuin-A concentrations in young and older high- and low-active men
Jenkins, N. T., McKenzie, J. A., Hagberg, J. M., & Witkowski, S. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.026 · Cited by 33
Magkos, F., Fabbrini, E., Patterson, B. W., Eagon, J. C., & Klein, S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.019 · Cited by 33
Han, K. J., Lee, S. Y., Kim, N., Chae, H., Lee, T., Jang, C., Yoo, K., Park, H. J., Lee, M., Jeon, W. S., et al. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.514 · Cited by 30
Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus
Zografou, I., Sampanis, C., Gkaliagkousi, Ε., Iliadis, F. S., Papageorgiou, T., Doukelis, P., Vogiatzis, K., & Δούμα, Σ. (2014) · HORMONES · doi:10.14310/horm.2002.1512 · Cited by 33
Abdominal Obesity and Brain Atrophy in Type 2 Diabetes Mellitus
Climie, R. E., Moran, C., Callisaya, M. L., Blizzard, L., Sharman, J. E., Venn, A., Phan, T. G., Beare, R. J., Forbes, J. M., Blackburn, N. B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142589 · Cited by 33
Gopalakrishnan, V., Pillai, S. I., & Subramanian, S. P. (2015) · Biochemistry Research International · doi:10.1155/2015/350829 · Cited by 33
Grosman, H., Fabre, B. R., López, M., Scorticati, C. H., Silva, M. L., Mesch, V., Mazza, O., & Berg, G. A. (2015) · The Aging Male · doi:10.3109/13685538.2015.1100600 · Cited by 33
Sung, K., Park, H., Kim, M., & Reaven, G. M. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0368-7 · Cited by 35
Type 2 diabetes exaggerates exercise effort and impairs exercise performance in older women
Huebschmann, A. G., Kohrt, W. M., Herlache, L., Wolfe, P., Daugherty, S. L., Reusch, J. E. B., Bauer, T. A., & Regensteiner, J. G. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000124 · Cited by 37
Lin, Y., Chen, Y., Hsieh, H.-H., & Chen, M. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.03.015 · Cited by 33
Hartvigsen, M. L., Jeppesen, P. B., Lærke, H. N., Njabe, E. N., Knudsen, K. E. B., & Hermansen, K. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf3043538 · Cited by 33
Reverri, E. J., Slupsky, C. M., Mishchuk, D. O., & Steinberg, F. M. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600132 · Cited by 33
Liang, S., Hu, Y., Liu, C., Qi, J., & Li, G. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0275-7 · Cited by 33
Validation of a metabolite panel for early diagnosis of type 2 diabetes
Carter, T. C., Rein, D., Padberg, I., Peter, E., Rennefahrt, U. E. E., David, D. E., McManus, V. D., Stefanski, E., Martin, S., Schatz, P., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.007 · Cited by 33
Gentile, M., Peluso, R., Minno, M. N. D. D., Costa, L., Caso, F., Simone, B. D., Iannuzzo, G., Scarpa, R., & Rubba, P. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3344-4 · Cited by 33
Zheng, Y., Ceglarek, U., Huang, T., Wang, T., Heianza, Y., Ma, W., Bray, G. A., Thiery, J., Sacks, F. M., & Qi, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1760 · Cited by 33
Lee, I., Wang, J., Fu, C., Lin, S., & Sheu, W. H. (2016) · Medicine · doi:10.1097/md.0000000000005260 · Cited by 33
Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients
Hu, Y., Liu, J., Dong, X., Xu, Y., Leng, S., & Wang, G. (2016) · Medical Science Monitor · doi:10.12659/msm.897924 · Cited by 33
Sánchez‐Enríquez, S., Ballesteros-Gonzalez, I. T., Villafán-Bernal, J. R., Pascoe-González, S., Rivera-León, E. A., Bastidas‐Ramírez, B. E., Rivas‐Carrillo, J. D., Alcalá-Zermeño, J. L., Armendáriz‐Borunda, J., Llamas-Covarrubias, I. M., et al. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i1.11 · Cited by 33
Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency
Ariyawatkul, K., Tepmongkol, S., Aroonparkmongkol, S., & Sahakitrungruang, T. (2017) · European Journal of Pediatrics · doi:10.1007/s00431-017-2875-2 · Cited by 35
Milan, A. M., Pundir, S., Pileggi, C. A., Markworth, J. F., Lewandowski, P. A., & Cameron‐Smith, D. (2017) · Nutrients · doi:10.3390/nu9040354 · Cited by 35
Zhang, L., Cordeiro, L., Liu, J., & Ma, Y. (2017) · Nutrients · doi:10.3390/nu9040384 · Cited by 36
Liu, F., Cottrell, J. J., Wijesiriwardana, U. A., Kelly, F., Chauhan, S. S., Pustovit, R. V., Gonzalez-Rivas, P. A., DiGiacomo, K., Leury, B. J., Celi, P., et al. (2017) · Translational Animal Science · doi:10.2527/tas2017.0014 · Cited by 34
Pittenger, S. R., Kao, C., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2017) · Fertility Research and Practice · doi:10.1186/s40738-017-0035-z · Cited by 33
Effects of metformin on endothelial health and erectile dysfunction
Patel, J. P., Lee, E. H., Mena, C. I., & Walker, C. N. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2017.03.52 · Cited by 33
Kay, B. A., Trigatti, K., MacNeil, M. B., Klingel, S. L., Repin, N. V., Goff, H. D., Wright, A. J., & Duncan, A. M. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.08.017 · Cited by 34
The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010–2011
Ahn, S. H., Seo, D. H., Kim, S. H., Nam, M., & Hong, S. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4257-z · Cited by 33
Eendebak, R. J. A. H., Ahern, T., Święcicka, A., Pye, S. R., O’Neill, T. W., Bártfai, G., Casanueva, F. F., Maggi, M., Forti, G., Giwercman, A., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13524 · Cited by 34
Resolution of type 2 diabetes after sleeve gastrectomy: a 2-step hypothesis
Sista, F., Abruzzese, V., Clementi, M., Guadagni, S., Montana, L., & Carandina, S. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.12.009 · Cited by 33
Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case–control study
Kalafati, I. P., Dimitriou, M., Borsa, D., Vlachogiannakos, J., Revenas, K., Kokkinos, A. D., Ladas, S. D., & Dedoussis, G. V. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1675-4 · Cited by 33
Meijnikman, A. S., Block, C. E. M. D., Verrijken, A., Mertens, I. L., & Gaal, L. F. V. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0310-0 · Cited by 33
Hellmuth, C., Lindsay, K. L., Uhl, O., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700889 · Cited by 33
Shih, K., & Kwok, C. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1025-y · Cited by 38
Bhupathiraju, S. N., Guasch‐Ferré, M., Gadgil, M. D., Newgard, C. B., Bain, J. R., Muehlbauer, M. J., Ilkayeva, O., Scholtens, D. M., Hu, F. B., Kanaya, A. M., et al. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy074 · Cited by 36
Leptin and Leptin receptor polymorphisms, plasma Leptin levels and obesity in Tunisian volunteers
Zayani, N., Hamdouni, H., Boumaiza, I., Fadoua, N., Asma, O., Fadhel, N. M., & Bouslama, A. (2018) · International Journal of Experimental Pathology · doi:10.1111/iep.12271 · Cited by 33
Kwon, H., Cho, J. H., Lee, W., Park, S. E., Park, C., Lee, W., Oh, K.-W., Park, H., & Rhee, E. (2018) · Clinical Endocrinology · doi:10.1111/cen.13823 · Cited by 33
Metabolic Syndrome, Thyroid Function and Autoimmunity - The PORMETS Study
Raposo, L., Martins, S., Ferreira, D., Guimarães, J. T., & Santos, A. C. (2018) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530318666180801125258 · Cited by 34
El-sheikh, H. M., El-Haggar, S. M., & Elbedewy, T. A. E. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.08.035 · Cited by 34
Circulating C1q/TNF‐related protein isoform 15 is a marker for the presence of metabolic syndrome
Mi, Q., Li, Y., Wang, M., Yang, G., Zhao, X., Liu, H., Zheng, H., & Li, L. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3085 · Cited by 33
Berks, D., Hoedjes, M., Raat, H., Franx, A., Looman, C. W. N., van Oostwaard, M. F., Papatsonis, D. N. M., Duvekot, J. J., & Steegers, E. A. P. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.12.004 · Cited by 35
O'Connor, S. E., Turcotte, A., Gagnon, C., & Rudkowska, I. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy074 · Cited by 34
Saleem, T. H., Dahpy, M. A., Ezzat, G. M., Abdelrahman, G., Abdel-Aziz, E. M., & Farghaly, R. (2019) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-019-02956-9 · Cited by 34
Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV
Weiner, L. D., Retuerto, M., Hager, C. L., Kamari, V. E., Shan, L., Sattar, A., Kulkarni, M., Funderburg, N., Ghannoum, M. A., Dirajlal‐Fargo, S., et al. (2019) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0252 · Cited by 33
Ren, G., Kim, T., Papizan, J. B., Okerberg, C. K., Kothari, V. M., Zaid, H., Bilan, P. J., Araya-Ramírez, F., Littlefield, L. A., Bowers, R. L., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00089.2018 · Cited by 34
Delitala, A., Scuteri, A., Fiorillo, E., Lakatta, E. G., Schlessinger, D., & Cucca, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060764 · Cited by 35
Zhu, C., Gao, J., Mei, F., Lu, L., Zhou, D., & Qu, S. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04063-4 · Cited by 35
Gumede, N. M., Lembede, B. W., Brooksbank, R. L., Erlwanger, K. H., & Chivandi, E. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2019.0120 · Cited by 33
Adriano, L. S., Dionísio, A. P., de Abreu, F. A. P., Carioca, A. A. F., Zocolo, G. J., Wurlitzer, N. J., PINTO, C. D. O., de Oliveira, A. C., & Sampaio, H. A. D. C. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108682 · Cited by 35
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
